After Pfizer, Serum Institute of India seeks emergency use authorisation for its COVID-19 vaccine ‘Covishield’
After Pfizer, Serum Institute of India seeks emergency use authorisation for its COVID-19 vaccine ‘Covishield’
New Delhi: After Pfizer, the Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation for its COVID-19 vaccine “Covishield” in the country. This comes a day after Pfizer India sought a similar approval from India’s drug regulator for its coronavirus vaccine. “SII has applied for […]